Table 2.

Effects of Selected Compounds

EC50, µM	Peak Count			Viability
Compounds	1 h	24 h	72 h	1 h	24 h	72 h
Rotenone	0.03	0.03	0.03		95.3	98.8
Valinomycin	0.84	0.09	0.05			>100
Deltamethrin	1.20	0.22	0.42		>100a	>100
Berberine chloride	11.3	1.19	0.45			96.3
2-Ethylhexyl diphenyl phosphate (EHDP)	4.14	1.53	3.65
Methyl mercuric(II) chloride	10.7	4.68	1.64			39.7
Tricresyl phosphate	7.65	3.01	2.95
Isodecyl diphenyl phosphate	12.2	3.25	0.23			104
Dichlorodiphenyltrichloroethane (DDT)	23.2	3.37	3.37
Dieldrin	19.5	3.43	8.89	>100	>100	>100
2,2′,4,4′,5-Pentabromodiphenyl ether (BDE-99)	No fitb	4.33	3.96	No fit	>100	>100
Diethylstilbestrol	15.1	11.5	21.4		>100	39.6
2,2′,4,4′-Tetrabromodiphenyl ether	36.1	11.9	1.21
Triphenyl phosphate	18.7	14.1	14.2			>100
Tris(chloropropyl) phosphate (TCPP)	31.7	38.5	10.3
Captan	c	42.7	104
Lead (II) acetate trihydrate	c	82.4	14.5			64.9
1-Ethyl-3-methylimidazolium diethylphosphate	No fit	108	136
2,3,7,8-Tetrachlorodibenzo-p-dioxin	No fit	No fit	6.03
Benzo(a)pyrene	No fit	No fit	8.67
Phenobarbital sodium salt	No fit	No fit	No fit
Dibenz[a,c]anthracene	No fit	No fit	No fit
Saccharin
Leucine

^aEstimated EC₅₀ values were above the highest tested concentration.

^bNo fit for the 4-parametric curve, but some observed effects.

^cBlank boxes correspond to no observed effects.